Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis

Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis

Edgar Carnero Contentti,1 Jorge Correale2,3 1Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Buenos Aires, Argentina; 2Department of Neurology, Fleni, Buenos Aires, Argentina; 3Universidad de Buenos Aires-CONICET, Instituto de Química y Fisicoquimí...

Full description

Bibliographic Details
Main Authors: Carnero Contentti E, Correale J
Format: Article
Language:English
Published: Dove Medical Press 2022-10-01
Series:Drug Design, Development and Therapy
Subjects:
multiple sclerosis
tyrosine kinase inhibitors
bruton's tyrosine kinase inhibitors
autoimmune diseases
experimental autoimmune encephalomyelitis
Online Access:https://www.dovepress.com/current-perspectives-evidence-to-date-on-btk-inhibitors-in-the-managem-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/current-perspectives-evidence-to-date-on-btk-inhibitors-in-the-managem-peer-reviewed-fulltext-article-DDDT

Similar Items